We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial.
- Authors
Aisen, Paul S; Schafer, Kimberly A; Grundman, Michael; Pfeiffer, Eric; Sano, Mary; Davis, Kenneth L; Farlow, Martin R; Jin, Shelia; Thomas, Ronald G; Thal, Leon J; Alzheimer's Disease Cooperative Study
- Abstract
Laboratory evidence that inflammatory mechanisms contribute to neuronal injury in Alzheimer disease (AD), along with epidemiological evidence, suggests that nonsteroidal anti-inflammatory drugs (NSAIDs) may favorably influence the course of the disease.
- Publication
JAMA, 2003, Vol 289, Issue 21, p2819
- ISSN
0098-7484
- Publication type
Journal Article
- DOI
10.1001/jama.289.21.2819